Moderate Effect of Duodenal-Jejunal Bypass Surgery on Glucose Homeostasis in Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

Moderate Effect of Duodenal-Jejunal Bypass Surgery on Glucose Homeostasis in Patients With Type 2 Diabetes

Published:2012-06 Issue:6 Volume:20 Page:1266-1272
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:

Author:

Klein Samuel,Fabbrini Elisa,Patterson Bruce W.,Polonsky Kenneth S.,Schiavon Carlos A.,Correa Jose L.,Salles Joao E.,Wajchenberg Bernardo L.,Cohen Ricardo

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/oby.2011.377/fullpdf

Reference25 articles.

1. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men;Chan;Diabetes Care,1994

2. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

3. Trends in A1C concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004;Ford;Diabetes Care,2008

4. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis;Buchwald;Am J Med,2009

5. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus;Pories;Ann Surg,1995

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enteroendocrine Reprogramming by Altered Epithelial-Mesenchymal Crosstalk in Metabolic Surgery;Journal of Metabolic and Bariatric Surgery;2024

2. Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats;Journal of Diabetes;2023-12-12

3. Updates in metabolic bariatric endoscopy;Digestive Endoscopy;2023-08-09

4. Endoscopic duodenal mucosal resurfacing for treating obesity and metabolic diseases: State-of-the-art review;International Journal of Gastrointestinal Intervention;2023-04-30

5. Worksite-based intensive lifestyle therapy has profound cardiometabolic benefits in people with obesity and type 2 diabetes;Cell Metabolism;2022-10